TRSBF 3SBio Inc. — dividend yield, history & ex-dividend dates
3SBio Inc. is a China-based investment holding company deeply engaged in the biopharmaceutical sector, encompassing the entire value chain from research and development to manufacturing, marketing, and sales of its innovative products. The company's extensive biopharmaceutical portfolio caters to a wide array of therapeutic needs. This includes treatments for various blood disorders like TPIAO (for chemotherapy-induced or immune thrombocytopenia), EPIAO and SEPO (recombinant erythropoietins for anemia), and SPARIN (a low-molecular-weight heparin for deep vein thrombosis prophylaxis and treatment, as well as for preventing clotting during hemodialysis), alongside Aiyishu for iron-deficiency anemia. Its autoimmune and inflammatory disease offerings feature YISAIPU, a tumor necrosis factor inhibitor effective against rheumatoid arthritis, ankylosing spondylitis, and psoriasis. In the oncology domain, 3SBio provides Cipterbin for HER2-positive metastatic breast cancer (in combination with chemotherapy), Intefen (a recombinant human interferon for lymphatic/hematopoietic malignancies and viral infections), and Inleusin (human interleukin-2 for renal cell carcinoma, melanoma, and thoracic fluid accumulation). Other specialized products address conditions such as male alopecia and alopecia areata (Mandi), acute rejection post-renal transplant (Xenopax), glycemic control in type 2 diabetes (Byetta), and diabetic retinopathy (Qiming Keli). In addition to its pharmaceutical operations, 3SBio diversifies its activities through services encompassing trading, project management, consulting, technology, and agriculture. The company has forged strategic collaboration agreements with a multitude of international partners, including prominent names like AstraZeneca, Lilly, Toray Industries Inc, Samsung Bioepis, Refuge Biotechnologies, Verseau, TLC, Numab, GenSight, Sensorion, and the Dana-Farber Cancer Institute. Established in 1993, the company maintains its headquarters in Shenyang, China.
Dividend Snapshot
Key Metrics
Current Yield
1.48%
At the Sep 14, 2026 price
The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.Annualized Dividend
$0.0319
The most recent payment scaled to a full year by how often it's paid. A $0.25 quarterly dividend annualizes to $1.00.Frequency
A Annual
How often the dividend is paid: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.Rank Score
61.9
As of Sep 14, 2026
Our 0-100 house score blending yield quality, payout sustainability (the trailing-twelve-month payout ratio), profitability (TTM return on equity), valuation (TTM price-to-book) and payment reliability, recomputed daily. Higher means a stronger profile on those factors in our model — a research score, not advice or a recommendation to buy.RSI (14)
26
As of Sep 14, 2026
Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.52-Week Range
$2.00 – $4.41
Closes through Sep 08, 2026
The lowest and highest price over the past year — shows where today's price sits in its recent range.Payout Ratio (TTM)
6.54%
12 months to Jun 30, 2026 (Q2 FY2026)
The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.Years Paying
8
How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.Price / Book (TTM)
1.27
Price as of Sep 14, 2026; latest reported book value
Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.S.A.F.E. Dividend Read
Quote & Key Data
Dividend Growth
Why the Yield Moved (90 Days)
TRSBF's dividend yield rose from 1.45% to 1.48% over the past ~90 days (+0.04 pp). Of that move, +0.00 pp came from changes in the dividend rate and +0.03 pp from the share price ($2.20 on Jun 16, 2026 → $2.15 on Sep 14, 2026). A yield that rises because the price fell is not an improvement in the payout itself.
Yield vs Its Own History
Across 332 daily observations over the past 16 months (through Sep 08, 2026), TRSBF's current yield is higher than approximately 87% of them. Our stored price history for TRSBF covers the past 16 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.
Adjusted Price History
Dividend History
Dividend Payment History
Ex-dividend calendar →| Amount | Type | Declared | Ex-Date | Record | Pay |
|---|---|---|---|---|---|
| $0.0319 A | Regular | - | Jul 21, 2026 | Jul 23, 2026 | Aug 04, 2026 |
| $0.0318 A | Regular | - | Jul 21, 2025 | Jul 23, 2025 | Aug 15, 2025 |
| $0.0320 A | Regular | - | Jul 22, 2024 | Jul 23, 2024 | Aug 05, 2024 |
| $0.0128 A | Regular | - | Jun 27, 2023 | Jun 28, 2023 | Jul 11, 2023 |
| $0.0255 A | Regular | - | Jun 27, 2022 | Jun 28, 2022 | Jul 11, 2022 |
| $0.0087 A | Regular | - | Jun 29, 2018 | Jul 03, 2018 | Jul 30, 2018 |
Peer Comparison
Selected Biotechnology dividend payers we cover, strongest DividendRank first — for context, not a recommendation.
| Ticker | Name | Yield | 5-Yr Growth | Streak | Rank |
|---|---|---|---|---|---|
| XOMAP | XOMA Corporation | 8.63% | - | 0 yrs | 54 |
| XOMAO | XOMA Corporation | 8.38% | - | 0 yrs | 52 |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.48% | - | 0 yrs | 45 |
| TECH | Bio-Techne Corporation | 0.44% | 0.0% | 0 yrs | 39 |
Related Guides & Lists
TRSBF dividend — frequently asked questions
Does 3SBio Inc. pay a dividend?
Yes. 3SBio Inc. (TRSBF) currently pays a dividend. The annualized dividend is about $0.03 per share, a yield of approximately 1.48%.
What is 3SBio Inc.'s dividend yield?
3SBio Inc.'s dividend yield is approximately 1.48%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.
How often does 3SBio Inc. pay dividends?
3SBio Inc. pays dividends annually — 1 time per year.
How long has 3SBio Inc. paid dividends?
3SBio Inc. has 8 years of dividend payments on record.
Data updated Sep 14, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.